pre_text: ITEM 6. SELECTED FINANCIAL DATA In December 2016, we acquired the 67% remaining interest in Inotera and began consolidating Inotera's operating results. In the periods presented above through December 2016, Inotera sold DRAM products exclusively to us through supply agreements. The cash paid for the Inotera Acquisition was funded, in part, with a term loan of 80 billion New Taiwan dollars and $986 million from the sale of 58 million shares of our common stock. See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Acquisition of Inotera."
table: 2019 2018 2017 2016 2015
table: (in millions, except per share amounts)
table: Revenue $23,406 $30,391 $20,322 $12,399 $16,192
table: Gross margin 10,702 17,891 8,436 2,505 5,215
table: Operating income 7,376 14,994 5,868 168 2,998
table: Net income (loss) 6,358 14,138 5,090 (275) 2,899
table: Net income (loss) attributable to Micron 6,313 14,135 5,089 (276) 2,899
table: Diluted earnings (loss) per share 5.51 11.51 4.41 (0.27) 2.47
table: Cash and short-term investments 7,955 6,802 5,428 4,398 3,521
table: Total current assets 16,503 16,039 12,457 9,495 8,596
table: Property, plant, and equipment 28,240 23,672 19,431 14,686 10,554
table: Total assets 48,887 43,376 35,336 27,540 24,143
table: Total current liabilities 6,390 5,754 5,334 4,835 3,905
table: Long-term debt 4,541 3,777 9,872 9,154 6,252
table: Total Micron shareholders' equity 35,881 32,294 18,621 12,080 12,302
table: Noncontrolling interests in subsidiaries 889 870 849 848 937
table: Total equity 36,770 33,164 19,470 12,928 13,239
question: Analyse this data from a financial earnings document. What percentage of total Micron shareholders' equity contributing to total equity in 2019?